Zofran Pregnancy Birth Defect Risks Remain Underappreciated by Doctors
While a growing number of Zofran lawsuits are being filed on behalf of children born with birth defects, the anti-nausea medication continues to be prescribed to pregnant women suffering from morning sickness due to the lack of warnings issued by the drug maker.
Zofran (ondansetron) is only approved by the FDA for treatment of nausea and vomiting among cancer and surgery patients. However, it is commonly prescribed off-label during pregnancy, accounting for a substantial portion of the annual sales for the drug over the past decade.
Several years ago, GlaxoSmithKline was accused of illegally promoting Zofran for off-label use among pregnant women, even though the drug maker never conducted studies to establish that it was safe for unborn children.
Learn More About Zofran lawsuits
Use of Zofran in Pregnancy May Increase the Risk that Children Suffer Cleft Palate, Cleft Lip, Heart Defects or Other Malformations.
Following the publication of independent research that has identified a potential risk of heart defects, cleft palate and other potential congenital malformations, GlaxoSmithKline now faces lawsuits that allege information about the potential Zofran pregnancy birth defect risks was withheld from consumers and the medical community.
Prior to becoming available as a generic in late 2006, Zofran was among the top selling drugs in the U.S., generating $1.3 billion in sales. According to a memorandum sent out in March of that year, the FDA estimated that nearly a quarter of Zofran prescriptions were made by OB/GYNs for use by pregnant women, which was the most frequent use of the drug.
Many doctors continue to assume that Zofran is safe during pregnancy due to prior marketing statements and materials provided by the drug maker.
Zofran Pregnancy Concerns
As early as 2006, a study published by Hong Kong researchers found that Zofran crosses the placenta in significant amounts when taken by pregnant women.
Researchers concluded that the “developmental significance of this drug exposure requires further investigation,” yet millions of women have continued to be prescribed the medication without warnings about the potential Zofran birth defect risks.
In November 2011, a study published in the medical journal Birth Defects Research Part A: Clinical and Molecular Teratology concluded that women may be 2.37 times more likely to give birth to a child with a cleft palate following Zofran use. This may leave children with a severe facial deformity, which can occur when development of the fetus is impacted during the first trimester.
Additional studies have also identified potential Zofran heart defect risks. An August 2013 study that reviewed data on more than 900,000 pregnancies in the Danish Medical Birth Registry found that children may be 2 to 4 times more likely to suffer a septal defect, involving holes in the heart, following Zofran exposure.
More recently, a study published by the medical journal Reproductive Toxicology in October 2014 found that there is a statistically significant increased risk for certain heart defects with Zofran use early in pregnancy.
Lawsuits filed on behalf of children born with birth defects claim that GlaxoSmithKline should have undertaken a comprehensive study on the potential pregnancy risks of Zofran and warned about the chance that unborn children may develop birth defects.
Plaintiffs claim that the drug maker placed their desire for profits before consumer safety, by essentially turning a blind eye to the mounting evidence in recent years, and by allowing doctors to continue to believe the medication is safe in pregnancy.
JordanAugust 21, 2015 at 12:21 am
I took Zofran the first trimester of my pregnancy. At 16 weeks we found that our baby was deceased. When I delivered him three days later, he was born with a clubbed foot, abdominal wall defect with intestines on the outside of the body and his leg was contracted. This was and still is absolutely devastating. I have tried for 12 years to have another baby. When I reached 12 weeks, I finally let my[Show More]I took Zofran the first trimester of my pregnancy. At 16 weeks we found that our baby was deceased. When I delivered him three days later, he was born with a clubbed foot, abdominal wall defect with intestines on the outside of the body and his leg was contracted. This was and still is absolutely devastating. I have tried for 12 years to have another baby. When I reached 12 weeks, I finally let myself get excited. After hearing of all the horrible effects of Zofran, I can't help but think my son could have made it had he not been exposed to Zofran. It deeply saddens me that there are so many babies living with these defects and many families who have endured losing a child like myself as a result of negligence. I hope that the effects of the lawsuits will force the company to stop marketing the drug to pregnant women. I wish I could rewind time and just puke the entire pregnancy. No amount of comfort is worth the emotional pain I live with everyday.
ConcernedApril 23, 2015 at 10:11 pm
Momofthree - How often did you take zofran? Also, when did you start taking it? We have been on it for 10 days before we found this information :(
momofthreeApril 21, 2015 at 5:17 pm
its amazes me to think the drug companies have known about this for nearly a decade and the category for this drug is still a B. They need to categorize it as a D so physicians stop prescribing it to pregnancy women! my child was born with 2 congenital defects... and yes I took Zofran during my first trimester not knowing it could harm my unborn baby. you may also find this interesting I never to[Show More]its amazes me to think the drug companies have known about this for nearly a decade and the category for this drug is still a B. They need to categorize it as a D so physicians stop prescribing it to pregnancy women! my child was born with 2 congenital defects... and yes I took Zofran during my first trimester not knowing it could harm my unborn baby. you may also find this interesting I never took it with my two older children and they were born without having any abnormalities whatsoever!
More Top Stories
A status conference being held today will cover a number of issues necessary to allow ParaGard IUD lawsuits to move forward in federal court.
The U.S. Judicial Panel on Multidistrict Litigation has consolidated all Neutrogena and Aveeno sunscreen spray recall lawsuits filed over benzene contamination before one judge for pretrial proceedings.
Seeking to avoid liability costs from talcum powder cancer lawsuits, Johnson & Johnson has broken off part of itself as a separate unit which includes talc liability claims, and had that unit declare bankruptcy.